The Global Non-Invasive Prenatal Testing Market Research Report Published By Emergen Research Has Been Formulated By Analysis Of Key Business Details And Extensive Geographical Spread Of The Non-Invasive Prenatal Testing Industry. The Study Offers Comprehensive Coverage Of The Qualitative And Quantitative Analysis Of The Non-Invasive Prenatal Testing Market Along With Crucial Statistical Data About The Non-Invasive Prenatal Testing Market. The Research Study Provides Historical Data From 2017 To 2018 And Offers Accurate Forecast Estimation Until 2027. The Report Also Profiles Established And Emerging Players Of The Market, Covering The Business Overview, Product Portfolio, Strategic Alliances, And Business Expansion Strategies.
Growth In The Non-Invasive Prenatal Testing (NIPT) Industry Is Guided By The High Probability Of Chromosomal Anomalies With Elevated Maternal Age, Increased Demand For Non-Invasive Procedures Over Invasive Approaches, Enhanced NIPT Reimbursement Scenario And Increased Understanding Of NIPT.
Non-Invasive Prenatal Testing Market Size – USD 3.08 Billion In 2019, Non-Invasive Prenatal Testing Market Growth – CAGR Of 13.9%, Non-Invasive Prenatal Testing Market Trends– High Demand From Developing Nations.
Key Participants Include Yourgene Health, Illumina Inc., Agilent Technologies Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Laboratory Corporation Of America Holdings, GE Healthcare, Perkinelmer Inc., BGI, And Natera Inc., Among Others.
Get A Free Sample Of The Report : https://www.emergenresearch.com/request-sample/16
With The Increasing Occurrence Of Pregnancy And Complications, Non-Invasive Prenatal Testing Is Expected To Become A Routine Procedure In The Future, Replacing Other, Riskier Screening Procedures. NIPT Has More Than 99% Identification Sensitivity And Shows Screening In Less Time Than Other Prenatal Screening Forms. So Few Players Provide Non-Invasive Pregnancy Monitoring. The High Cost Of Research And The Interim Diagnostic Method Restrains Business Expansion.
The constant efforts of prominent players to develop newer and modern technologies and product advancements are expected to drive the growth of the industry over the coming years. The report studies the extensive business expansion plans and advancements in R&D activities and product portfolio. The report offers a clear understanding of the alliances in the market, such as mergers and acquisitions, joint ventures, collaborations, partnerships, agreements, product launches and brand promotions, and corporate deals.
The NGS Technology, Along With Cfdna Research, Has Paved The Way For The Identification Of Chromosomal Aberrations With Growing Efficiency And Lowering Expense. The High-Risk Testing Industry Is Crowded, And Continued Rivalry Is Likely To Result In Substantial Declines In The Retail Sales Price Of Such Tests. The Prevalence Of Such Studies Can Be Improved With Reduced Costs In The Market For Reproductive Genetics. The Creation Of New Technology For NIPT Is Gradually Increasing Due To The Rising Awareness Of The Advantages Of Non-Invasive Methods.
Annually, An Average USD 4,879.0 Is Expended On Child Healthcare In The U.S., Which Is Expected To Benefit The Non-Invasive Pregnancy Testing Sector In North America, According To Work Conducted By The Health Expense Institute. Due To The Increasing Focus On Minimally Invasive Diagnostic Procedures And Preference For Early Detection Of Illness, The Recognition Among Citizens And Expanding Healthcare Services, Asia Pacific Is Projected To Grow Significantly In The Global Market For Non-Invasive Prenatal Research.
The Report Offers Insightful Information About The Market Dynamics Of The Non-Invasive Prenatal Testing Market. It Offers SWOT Analysis, PESTEL Analysis, And Porter’s Five Forces Analysis To Present A Better Understanding Of The Non-Invasive Prenatal Testing Market, Competitive Landscape, Factors Affecting It, And To Predict The Growth Of The Industry. It Also Offers The Impact Of Various Market Factors Along With The Effects Of The Regulatory Framework On The Growth Of The Non-Invasive Prenatal Testing Market.
Further Key Findings From The Report Suggest
Based On The Method, Ultrasound Detection Generated A Revenue Of USD 0.86 Billion In 2019 And Believed To Rise With A CAGR Of 14.0% In The Forecast Period, Owing To The Ability Of The Ultrasound Diagnosis To Detect Anomalies In The Position Of The Baby And Actions Within The Womb.
The Hospital Segment Expected To Grow With A CAGR Of 14.1% In The Forecasted Period Due To The Growing Introduction Of Non-Invasive Prenatal Testing Coupled With Rapid Technological Developments And Groundbreaking Acceptance Strategies.
The Trisomy Application Is The Major Contributor To The Non-Invasive Prenatal Testing Market. The Trisomy Application Of The North America Region Is The Major Shareholder Of The Market And Held Around 45.1% Of The Market In The Year 2019, Owing To The High Incidence Of Genetic Disorders Correlated With Trisomy’s, Such As Patau Syndrome, Down Syndrome, And Edward Syndrome.
Request Customization Of The Report: https://www.emergenresearch.com/request-for-customization/16
North America Dominated The Market For Non-Invasive Prenatal Testing In 2019 Due To The Availability Of Technologically Advanced Healthcare Research System, The Region’s Production Of WGS. The North America Region Held Approximately 48.8% Of The Market, Followed By Europe, Which Contains Around 25.4% Market In The Year 2019.
For The Purpose Of This Report, Emergen Research Has Segmented Into The Global Non-Invasive Prenatal Testing Market Based On The Method, End-Use, Application, And Region:
Method Outlook (Revenue, USD Billion; 2017-2027)
- Ultrasound Detection
- Biochemical Screening Tests
- Cell-Free DNA In Maternal Plasma Tests
End-Use Outlook (Revenue, USD Billion; 2017-2027)
- Diagnostic Laboratories
- Research Centers
Application Outlook (Revenue, USD Billion; 2017-2027)
- Microdeletion Syndrome
Key Questions Addressed In The Report:
- Who Are The Leading Players Dominating The Global Non-Invasive Prenatal Testing Market?
- Which Factors Could Potentially Hamper The Global Market Growth During The Forecast Period?
- Which Regional Market Offers The Most Attractive Growth Opportunities To The Companies Operating In This Market?
- How Is The Raw Material Availability Affecting The Demand For Non-Invasive Prenatal Testing In This Industry Vertical?
Table Of Content
Chapter 1. Market Synopsis
1.1. Market Definition
1.2. Research Scope & Premise
1.4. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter 3. Indicative Metrics
Chapter 4. Non-Invasive Prenatal Testing Market Segmentation & Impact Analysis
4.1. Non-Invasive Prenatal Testing Market Product Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market Indicators Analysis
4.2.2. Market Drivers Analysis
22.214.171.124. High Risk Of Chromosomal Abnormalities With Increasing Maternal Age
126.96.36.199. Untapped Emerging Markets
4.2.3. Market Restraints Analysis
188.8.131.52. Reliability Of Test Results, Especially In Obese Women
4.3. Technological Insights
4.4. Regulatory Framework
4.5. ETOP Analysis
4.6. Porter’s Five Forces Analysis
4.7. Competitive Metric Space Analysis
4.8. Price Trend Analysis
4.9. Customer Mapping
4.10. Covid-19 Impact Analysis
4.11. Global Recession Influence
Chapter 5. Non-Invasive Prenatal Testing Market By Method Insights & Trends
5.1. Method Dynamics & Market Share, 2020 & 2027
5.2. Ultrasound Detection
5.2.1. Market Estimates And Forecast, 2017 – 2027 (USD Billion) (Kilotons)
5.2.2. Market Estimates And Forecast, By Region, 2017 – 2027 (USD Billion) (Kilotons)
5.3. Biochemical Screening Tests
5.3.1. Market Estimates And Forecast, 2017 – 2027 (USD Billion) (Kilotons)
5.3.2. Market Estimates And Forecast, By Region, 2017 – 2027 (USD Billion) (Kilotons)
5.4. Cell-Free DNA In Maternal Plasma Tests
5.4.1. Market Estimates And Forecast, 2017 – 2027 (USD Billion) (Kilotons)
5.4.2. Market Estimates And Forecast, By Region, 2017 – 2027 (USD Billion) (Kilotons)
5.5.1. Market Estimates And Forecast, 2017 – 2027 (USD Billion) (Kilotons)
5.5.2. Market Estimates And Forecast, By Region, 2017 – 2027 (USD Billion) (Kilotons)
precision medicine market
craniomaxillofacial devices market
pediatric psoriasis market
clinical decision support systems market
At Emergen Research, We Believe In Advancing With Technology. We Are A Growing Market Research And Strategy Consulting Company With An Exhaustive Knowledge Base Of Cutting-Edge And Potentially Market-Disrupting Technologies That Are Predicted To Become More Prevalent In The Coming Decade.
Corporate Sales Specialist
Emergen Research | Web: Www.Emergenresearch.Com
Direct Line: +1 (604) 757-9756
E-Mail: [email protected]